Contemporary NSTEMI management: the role of the hospitalist

References

• Thygesen K, Alpert JS, Jaffe AS, et al. Fourth universal definition of myocardial infarction. Circulation. 2018;138:e618–e651.
   PubMed Web of Science ®Google Scholar
• EA A, Wenger NK, Bindis RG, et al. AHA/ACC guideline for the management of patients with non-ST-elevation acute coronary syndromes: a report of the american college of cardiology/american heart association task force on practice guidelines. J Am Coll Cardiol. 2014;64(24):e139–e228.
   PubMed Web of Science ®Google Scholar
• Sandoval Y, Jaffe AS. Type 2 myocardial infarction: JACC review topic of the week. J Am Colloid Cardiol. 2019;73(14):1846–1860.
   PubMed Web of Science ®Google Scholar
• Malanchini G, Stafanini GG, Malanchini M, et al. Higher in-hospital mortality during weekend admission for acute coronary syndrome: a large-scale cross-sectional italian study. J Cardiovasc Med. 2019;20(2):74–80.
   Google Scholar
• Villanueva T, Gurunathan R, Humber D, et al. A guide for effective quality improvement: improving acute coronary syndrome care for hospitalized patients. Soc Hosp Med. 2005. Available from: https://shm.hospitalmedicine.org/acton/attachment/25526/f-0480/1/-/-/-/-/SHM_Acute_Coronary_Sydrome_Guide.pdf
   Google Scholar
• RM W, Goldman L. Zero to 50,000—the 20th anniversary of the hospitalist. NEJM. 2016;375(11):1009–1011. Wachter, R, et al.
   PubMed Web of Science ®Google Scholar
• SR R, Rosenman DJ, Amin AN, et al. Hospital medicine fellowships: works in progress. Am J Med. 2006;119(1):71–77.
   Google Scholar
• Society of hospital medicine. [cited 2019 16 May]. Available from: hospitalmedicine.org
   Google Scholar
• Berchuck CA New hospitalist model for managing high-cost, high-need patients. Harvard Business Review Digital Article. [cited 2019 May 17]. Available from: hbr.org,published10/9/2018
   Google Scholar
• Pistoria M, et al. The core competencies in hospital medicine: a framework for curriculum development by the society of hospital medicine. J Hosp Med. 2006;1(supplement 1):2–95.
   PubMed Web of Science ®Google Scholar
• Nichani S, Fitterman N, Lukela M, et al. Core Competencies: acute Coronary Syndrome. Hospital Medicine Revised Core Competency. J Hosp Med. 2017;12(4):S1–2.
   PubMedGoogle Scholar
• CA H, Howell EE, Bush DE, et al. Chest pain relief by nitroglycerin does not predict active coronary artery disease. Ann Intern Med. 2003;139(12):979–986.
   PubMed Web of Science ®Google Scholar
• TF L. Acute coronary syndromes: the impressive impact of guideline-based management in NSTEMI. Eur Heart J. 2018;39(42):3753–3756.
   PubMed Web of Science ®Google Scholar
• Roffi M, Patrono C, Collet JP, et al. 2015 ESC guidelines for the management of acute coronary syndrome in patients presenting without persistent ST-segment elevation. Eur Heart J. 2016;37(3):267–315. Roffi, R, et al.
   PubMed Web of Science ®Google Scholar
• SR M, Granger CB, Boden WE, et al. Early versus delayed invasive intervention in acute coronary syndromes. NEJM. 2009;360(21):2165–2175.
   PubMed Web of Science ®Google Scholar
• EM A, Cohen M, Bernick PJLM, et al. The TIMI risk score for unstable angina/non-ST elevation MI: a method for prognostication and therapeutic decision making. JAMA. 2000;284(7):835–842.
   PubMed Web of Science ®Google Scholar
• KAA F, Dabbous OH, Goldberg RJ, et al. Prediction of risk of death and myocardial infarction in the six months after presentation with acute coronary syndrome: prospective multinational observational study (GRACE). BMJ. 2006;333:1091.
   PubMedGoogle Scholar
• Boersma E, Pieper KS, Wilcox RG, et al. predictors of outcome in patients with acute coronary syndromes without persistent st-segment elevation. results from an international trial of 9461 patients. The PURSUIT investigators. Circulation. 2000;101(22):2557–2567.
   PubMed Web of Science ®Google Scholar
• Subherwal S, Bach RG, Chen AY, et al. Baseline of major bleeding in non-ST-segment-elevation myocardial infarction: the CRUSADE (can rapid risk stratification of unstable angina patients suppress adverse outcomes with early implementation of the ACC/AHA guidelines) bleeding score. Circulation. 2009;119(14):1873–1882.
   PubMed Web of Science ®Google Scholar
• Antoniou S, Colicchia M, Guttmann OP, et al. Risk scoring to guide antiplatelet therapy post-percutaneous coronary intervention for acute coronary syndrome results in improved clinical outcomes. Eur Heart J Qual Care Clin Outcomes. 2017;4(4):284–289.
   Web of Science ®Google Scholar
• Paiva L, Providencia R, Barra SN, et al. Improving risk stratification in non-ST-segment elevation myocardial infarction with combined assessment of GRACE and CRUSADE risk scores. Arch Cardiovasc Dis. 2014;107(12):681–689.
   PubMed Web of Science ®Google Scholar
• Cordero A, Rodriguez-Manero M, Garcia-Acuna JM, et al. Additive value of the CRUSADE score to the GRACE score for mortality risk prediction in patients with acute coronary syndromes. Int J Cardiol. 2017;245:1–5.
   PubMed Web of Science ®Google Scholar
• Droppa M, Geisler T. What is the role of cangrelor in patients undergoing PCI? Curr Vasc Pharmacol. 2018;16(5):484–489.
   PubMed Web of Science ®Google Scholar
• Faridi KF, Peterson ED, McCoy LA, et al. Timing of first postdischarge follow-up and medication adherence after acute myocardial infarction. JAMA Cardiol. 2016;1(2):147–155.
   PubMed Web of Science ®Google Scholar
• Montalescot G, Bolognese L, Dudek D, et al. Pretreatment with prasugrel in non-ST-segment elevation acute coronary syndromes. NEJM. 2013;369:999–1010.
   PubMed Web of Science ®Google Scholar
• Roe MT, Armstrong PW, Fox KAA, et al. Prasugrel versus clopigogrel for acute coronary syndromes without revascularization. NEJM. 2012;367:1297–1309.
   PubMed Web of Science ®Google Scholar
• Yusuf S, Zhao F, Mehta SR, et al. Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without st-segment elevation. NEJM. 2001;345:494–502.
   PubMed Web of Science ®Google Scholar
• Mehta SR, Bassand JP, Chrolavicius, et al. Dose comparisons of clopidogrel and aspirin in acute coronary syndromes. NEJM. 2010;363:930–942.
   PubMed Web of Science ®Google Scholar
• Held C, Asenblad N, Bassand JP, et al. Ticagrelor versus clopidogrel in patients with acute coronary syndromes undergoing coronary artery bypass surgery: results from the PLATO (platelet inhibition and patient outcomes) trial. J Am Coll Cardiol. 2011;57(6):672–684.
   PubMed Web of Science ®Google Scholar
• Pollack CV Jr, Davoudi F, Diercks DB, et al. Relative efficacy and safety of ticagrelor vs clopidogrel as a function of time to invasive management in non-st-segment elevation acute coronary syndrome in the PLATO trial. Clin Cardiol. 2017;40(6):390–398.
   PubMed Web of Science ®Google Scholar
• James S, Budaj A, Aylward P, et al. Ticagrelor versus clopidogrel in acute coronary syndromes in relation to renal function: results from the Platelet Inhibition and Patient Outcomes (PLATO) trial. Circulation. 2010;122:1056–1067.
   PubMed Web of Science ®Google Scholar
• Lindholm D, Varenhorst C, Cannon CP, et al. Ticagrelor vs. clopidogrel in patients with non-ST-elevation acute coronary syndrome with or without revascularization: results from the PLATO trial. Eur Heart J. 2014;35:2083–2093.
   PubMed Web of Science ®Google Scholar
• Bhatt DL, Pollack CV, Weitz JI, et al. Antibody-based ticagrelor reversal agent in healthy volunteers. NEJM. 2019;380(19):1825-1833.
   Google Scholar
• Pollack CV, Bhandary DD, Frost A, et al. Abstract 12797: updated report from an emergency department-based registry of NSTEMI patients given upstream advanced oral anti-platelet therapy. Circulation. 2018;138:A12797.
   Google Scholar
• Corbelli JC, Janicke DM, Cziraky MJ, et al. Acute coronary syndrome emergency treatment strategies: improved treatment and reduced mortality in patients with acute coronary syndrome using guideline-based critical care pathways. Am Heart J. 2009;157(1):61–88.
   PubMed Web of Science ®Google Scholar
• Mathews R, Wang TY, Honeycutt E, et al. Persistence with secondary prevention medications after acute myocardial infarction: insights from the TRANSLATE-ACS study. Am Heart J. 2015;170(1):62–69.
   PubMed Web of Science ®Google Scholar
• JA R, Kaltenbach LA, Anstrom KJ, et al. hospital evaluation of health literacy and associated outcomes in patients after acute myocardial infarction. Am Heart J. 2018;198:97–107.
   PubMed Web of Science ®Google Scholar
• Sheyin O, Davies O, Duan W, et al. The prognostic significance of troponin elevation in patients with sepsis: a meta-analysis. Heart Lung. 2015;44(1):75–81.
   PubMed Web of Science ®Google Scholar
• Crewdson K, Thompson J, Thomas M. Cardiac troponin T is associated with mortality in patients admitted to critical care in a UK major trauma centre: a retrospective database analysis. J Intensive Care Soc. 2019;20(2):132–137.
   PubMedGoogle Scholar
• Ahn SH, Lee JS, Kim YH, et al. Prognostic significance of troponin elevation for long-term mortality after ischemic stroke. J Stroke. 2017;19(3):312–322.
   PubMed Web of Science ®Google Scholar
• Oberweis BS, Smilowitz NR, Nukala S, et al. Relation of perioperative elevation of troponin to long-term mortality after orthopedic surgery. Am J Cardiol. 2015;115(12):1643–1648.
   PubMed Web of Science ®Google Scholar
• Harvell B, Henrie N, Ernst AA, et al. The meaning of elevated troponin i levels: not always acute coronary syndromes. Am J Emerg Med. 2016;34(2):145–148.
   PubMed Web of Science ®Google Scholar
• Webb IG, Yam ST, Cooke R, et al. Elevated baseline cardiac troponin levels in the elderly—another variable to consider. Heart Lung Circ. 2015;24(2):142–148.
   PubMed Web of Science ®Google Scholar
• Petrilli CM, Giacherio DA. annals for hospitalists inpatient notes – clinical pearls—a middle aged man with pneumonia and elevated high-sensitivity troponin levels. Ann Intern Med. 2018;169(8):H02–H03.
   Web of Science ®Google Scholar
• Jeetley P, Senior R. clinical echocardiography: coronary artery disease: assessing regional wall motion. In: Kisslo PJ, editor. Echocardiography, nihoyannopoulous. Cham: Springer; 2018. p. 313–324.
   Google Scholar
• Nugent JP, Wang J, Louis LJ, et al. CCTA in patients with positive troponin and low clinical suspicion for ACS: a useful diagnostic option to exclude obstructive CAD. Emerg Radiol. 2019;26(3):1–7.
   PubMed Web of Science ®Google Scholar
• Lemor A, Hernandez GA, Patel N, et al. Predictors and etiologies of 30-day readmissions in patients with non-ST-elevation acute coronary syndrome. Catheter Cardiovasc Interv. 2019;93(3):373–379.
   PubMed Web of Science ®Google Scholar
• Thomas RJ, Balady G, Banka G, et al. ACC/AHA clinical performance and quality measures for cardiac rehabilitation: a report of the american college of cardiology/american heart association task force on performance measures. J Am Colloid Cardiol. 2018;71(16):1814–1837.
   PubMed Web of Science ®Google Scholar
• Doll JA, Hellkamp A, Ho PM, et al. Participation in cardiac rehabilitation programs among older patients after acute myocardial infarction. JAMA Intern Med. 2015;175(10):1700–1702.
   PubMed Web of Science ®Google Scholar
• Beatty AL, Li S, Thomas L, et al. Trends in referral to cardiac rehabilitation after myocardial infarction: data from the national cardiovascular data registry 2007 to 2012. J Am Colloid Cardiol. 2014;63(23): 2682–2583.
   PubMed Web of Science ®Google Scholar
• Lopes RD, Heizer G, Aronson R, et al. Antithrombotic therapy after acute coronary syndrome or PCI in atrial fibrillation. NEJM. 2019;380:1509–1524.
   PubMed Web of Science ®Google Scholar
• Goff DC Jr, Lloyd-Jones DM, Bennett G, et al. 2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American college of cardiology/American heart association task force on practice guidelines. Circulation. 2014;129(25 Supplement 2):S49–73.
   PubMed Web of Science ®Google Scholar
• Morrone D, Weintraub WS, Toth PP, et al. Lipid-altering efficacy of ezetimibe plus statin and statin monotherapy and identification of factors associated with treatment response: a pooled analysis of over 21,000 subjects from 27 clinical trials. Atherosclerosis. 2012;223:251–261.
   PubMed Web of Science ®Google Scholar
• Sabatine MS. pcsk9 inhibitors: clinical evidence and implementation. Nat Rev Cardiol. 2019;16(3):155–165.
   PubMed Web of Science ®Google Scholar
• TA Z, Wiviott SD, Raz I, et al. SGLT2 inhibitors for primary and secondary prevention of cardiovascular and renal outcomes in type 2 diabetes: a systematic review and meta-analysis of cardiovascular outcome trials. Lancet. 2019;393(10166):31–39.
   PubMed Web of Science ®Google Scholar
• O’Sullivan JW. Prevention of cardiovascular disease and renal failure in type 2 diabetes: sodium-glucose cotransporter-2 (SGLT2) inhibitors. BMJ Evid Based Med. 2019 July 31. Published Online First. Accessed 10/21/19. DOI:10.1136/bmjebm-2019-111231
   Google Scholar
• [cited 2019 OCT 13]. Available from: https://www.biospace.com/article/astrazeneca-s-diabetes-drug-farxiga-looks-promising-for-heart-failure/
   Google Scholar
• Rymer J, Fonseca E, Bhandary D, et al. Difference in medication adherence between patients filling 30- versus 90-day prescription supply after acute myocardial infarction. J Am Coll Cardiol. 2018;71(Suppl):69.
   PubMedGoogle Scholar
• Budoff MJ, Bloom SA, Chow BJ, et al. Coronary computed tomography angiography predicts subsequent cardiac outcome events: results of the visipaque CCTA registry study. Coron Artery Dis. 2015;26(4): 301-07.
   Web of Science ®Google Scholar
• O’Brien EC, McCoy LA, Thomas L, et al. Patient adherence to generic versus brand statin therapy after acute myocardial infarction: insights from the can rapid stratification of unstable angina patients suppress adverse outcomes with early implementation of the American college of cardiology/American heart association guidelines registry. Am Heart J. 2015;170:55–61.
   PubMed Web of Science ®Google Scholar
• Cheng K, Ingram N, Keenan J, et al. Evidence of poor adherence to secondary prevention after acute coronary syndromes: possible remedies through the application of new technologies. Open Heart. 2015;2(1):1–7.
   Web of Science ®Google Scholar
• Levy AE, Huang C, Huang A, et al. Recent approaches to improve medication adherence in patients with coronary heart disease: progress towards a learning healthcare system. Curr Atheroscler Rep. 2018;20(1):5.
   PubMed Web of Science ®Google Scholar